Publikationen: Prof. Dr. rer. nat. Volker Schirrmacher Archive | IOZK

Beiträge

Evidence-Based Medicine in Oncology: Commercial Versus Patient Benefit

2020-07-23/in Dendritic Cells, Hyperthermia, International Publications, Newcastle Disease Virus /von 2020-07-23 / Biomedicines 2020 Jul;8(8)

Position paper: new insights into the immunobiology and dynamics of tumor-host interactions require adaptations of clinical studies

2020-06-30/in Dendritic Cells, Hyperthermia, International Publications, Newcastle Disease Virus /von 2020-06-30 / Expert Rev Anticancer Ther 2020 Jun;:1-8

New Insights into Mechanisms of Long-term Protective Anti-tumor Immunity Induced by Cancer Vaccines Modified by Virus Infection

2020-03-06/in Dendritic Cells, International Publications, Newcastle Disease Virus /von 2020-03-06 / Biomedicines 2020 Mar;8(3)

Breaking Therapy Resistance: An Update on Oncolytic Newcastle Disease Virus for Improvements of Cancer Therapy

2019-08-30/in Checkpoint-Inhibitors, Dendritic Cells, International Publications, Newcastle Disease Virus /von 2019-08-30 / Biomedicines 2019 Aug;7(3)

Immunobiology of Newcastle Disease Virus and Its Use for Prophylactic Vaccination in Poultry and as Adjuvant for Therapeutic Vaccination in Cancer Patients

2017-05-20/in International Publications, Newcastle Disease Virus /von 2017-05-20 / Int J Mol Sci 2017 May;18(5)

Oncolytic Newcastle disease virus as a prospective anti-cancer therapy. A biologic agent with potential to break therapy resistance

2015-10-05/in International Publications, Newcastle Disease Virus /von 2015-10-05 / Expert Opin Biol Ther 2015;15(12):1757-71

Long-term survival of a breast cancer patient with extensive liver metastases upon immune and virotherapy: a case report

2015-05-28/in Breast Cancer, Dendritic Cells, Hyperthermia, International Publications, Newcastle Disease Virus /von 2015-05-28 / Immunotherapy 2015;7(8):855-60

Strong T‑cell costimulation can reactivate tumor antigen‑specific T cells in late‑stage metastasized colorectal carcinoma patients: results from a phase Ⅰ clinical study

2014-10-06/in International Publications, Newcastle Disease Virus /von 2014-10-06 / Int. J. Oncol. 2015 Jan;46(1):71-7

Multimodal cancer therapy involving oncolytic newcastle disease virus, autologous immune cells, and bi-specific antibodies

2014-09-11/in Dendritic Cells, International Publications, Newcastle Disease Virus /von 2014-09-11 / Front Oncol 2014;4:224

Autologous tumor cell vaccines for post-operative active-specific immunotherapy of colorectal carcinoma: long-term patient survival and mechanism of function

2014-01-01/in Colorectal Cancer, Dendritic Cells, International Publications /von 2014-01-01 / Expert Rev Vaccines 2014 Jan;13(1):117-30